Stephen A Berry

Title: The Innovations of Stephen A Berry

Introduction

Stephen A Berry is a notable inventor based in Saratoga, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of high dose formulations. With a total of 4 patents to his name, Berry's work has had a considerable impact on medication delivery systems.

Latest Patents

Berry's latest patents include innovative formulations that enhance the efficacy of certain medications. One of his patents focuses on high dose formulations of mycophenolate mofetil and mycophenolic acid. This invention allows for the convenient manufacturing of high dose oral formulations through the hot melt filling of a supercooled liquid into a pharmaceutical dosage form. Another significant patent involves high dose ranolazine formulations, which similarly utilizes the hot melt filling technique to create effective oral pharmaceutical formulations.

Career Highlights

Stephen A Berry is currently associated with Syntex (U.S.A.) Inc., where he continues to advance pharmaceutical innovations. His work has been instrumental in improving the manufacturing processes of high dose medications, thereby enhancing patient outcomes.

Collaborations

Berry has collaborated with esteemed colleagues such as Glenn J Samuels and Jung-Chung Lee. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Stephen A Berry is a prominent inventor whose work in high dose pharmaceutical formulations has made a significant impact in the industry. His contributions continue to shape the future of medication delivery systems.